These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34734029)

  • 1. Effects of voriconazole on population pharmacokinetics and optimization of the initial dose of tacrolimus in children with chronic granulomatous disease undergoing hematopoietic stem cell transplantation.
    Chen X; Wang D; Lan J; Wang G; Zhu L; Xu X; Zhai X; Xu H; Li Z
    Ann Transl Med; 2021 Sep; 9(18):1477. PubMed ID: 34734029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and initial dose optimization of tacrolimus in children with severe combined immunodeficiency undergoing hematopoietic stem cell transplantation.
    Chen X; Wang D; Zheng F; Zhai X; Xu H; Li Z
    Front Pharmacol; 2022; 13():869939. PubMed ID: 35935844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Posaconazole on Tacrolimus Population Pharmacokinetics and Initial Dose in Children With Crohn's Disease Undergoing Hematopoietic Stem Cell Transplantation.
    Chen X; Wang D; Zheng F; Zhu L; Huang Y; Zhu Y; Huang Y; Xu H; Li Z
    Front Pharmacol; 2022; 13():758524. PubMed ID: 35496296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial Dosage Optimization of Tacrolimus in Pediatric Patients With Thalassemia Major Undergoing Hematopoietic Stem Cell Transplantation Based on Population Pharmacokinetics.
    Zhou S; Zhang R; Lv C; Lu J; Wei Y; Li C; Chen M; Li Q; Liu T
    Ann Pharmacother; 2021 Apr; 55(4):440-451. PubMed ID: 32924532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of initial dose regimen of tacrolimus in paediatric lung transplant recipients based on Monte Carlo simulation.
    Wang DD; Mei YQ; Yang L; Ding KW; Xue JJ; Wang X; He SM; Wei QL
    J Clin Pharm Ther; 2022 Oct; 47(10):1659-1666. PubMed ID: 35716040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation.
    Iwamoto T; Monma F; Fujieda A; Nakatani K; Gayle AA; Nobori T; Katayama N; Okuda M
    Ther Drug Monit; 2015 Oct; 37(5):581-8. PubMed ID: 25565672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the initial tacrolimus dosage in Chinese children with lung transplantation within normal hematocrit levels.
    Hu K; He SM; Zhang C; Zhang YJ; Gu Q; Shi HZ; Wang DD
    Front Pediatr; 2024; 12():1090455. PubMed ID: 38357508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Voriconazole Exposure on the Pharmacokinetics of Tacrolimus in Lung Transplantation Patients, Based on Therapeutic Drug Monitoring Data.
    Chen W; Wang X; Li B; Qin W; Li S; Wang X; Chen W; Zhang X; Li P; Zuo X
    J Clin Pharmacol; 2022 Oct; 62(10):1310-1320. PubMed ID: 35485761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients.
    Liu XL; Guan YP; Wang Y; Huang K; Jiang FL; Wang J; Yu QH; Qiu KF; Huang M; Wu JY; Zhou DH; Zhong GP; Yu XX
    Front Pharmacol; 2022; 13():891648. PubMed ID: 35873585
    [No Abstract]   [Full Text] [Related]  

  • 10. CYP2C19 Phenotype and Body Weight-Guided Voriconazole Initial Dose in Infants and Children after Hematopoietic Cell Transplantation.
    Takahashi T; Mohamud MA; Smith AR; Jacobson PA; Jaber MM; Alharbi AF; Fisher J; Kirstein MN
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0062321. PubMed ID: 34097481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight, CYP3A5 Genotype, and Voriconazole Co-administration Influence Tacrolimus Initial Dosage in Pediatric Lung Transplantation Recipients with Low Hematocrit based on a Simulation Model.
    Hu K; Pan JJ; Qu WQ; He SM; Yang Y; Shi HZ; Zhang YJ; Chen X; Wang DD
    Curr Pharm Des; 2024 Aug; ():. PubMed ID: 39129279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients.
    Cai X; Song H; Jiao Z; Yang H; Zhu M; Wang C; Wei D; Shi L; Wu B; Chen J
    Eur J Pharm Sci; 2020 Sep; 152():105448. PubMed ID: 32621968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation.
    Cole T; Pearce MS; Cant AJ; Cale CM; Goldblatt D; Gennery AR
    J Allergy Clin Immunol; 2013 Nov; 132(5):1150-5. PubMed ID: 23870668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics model and initial dose optimization of tacrolimus in children and adolescents with lupus nephritis based on real-world data.
    Chen X; Wang DD; Xu H; Li ZP
    Exp Ther Med; 2020 Aug; 20(2):1423-1430. PubMed ID: 32765671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients.
    Wang D; Chen X; Xu H; Li Z
    Xenobiotica; 2020 Feb; 50(2):178-185. PubMed ID: 30938547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and pharmacogenomics of tacrolimus in Chinese children receiving a liver transplant: initial dose recommendation.
    Chen X; Wang DD; Xu H; Li ZP
    Transl Pediatr; 2020 Oct; 9(5):576-586. PubMed ID: 33209719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the blood concentrations of tacrolimus and voriconazole in hematopoietic stem cell transplant recipients
.
    Ota R; Hirata A; Noto K; Yokoyama S; Hosomi K; Takada M; Matsuoka H
    Int J Clin Pharmacol Ther; 2019 Nov; 57(11):561-566. PubMed ID: 31426903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.
    Mimura A; Yamaori S; Ikemura N; Katsuyama Y; Matsuzawa N; Ohmori S
    J Clin Pharm Ther; 2019 Aug; 44(4):565-571. PubMed ID: 30950099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation.
    Mori T; Kato J; Yamane A; Sakurai M; Kohashi S; Kikuchi T; Ono Y; Okamoto S
    Int J Hematol; 2012 May; 95(5):564-9. PubMed ID: 22461034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study.
    Hikasa S; Shimabukuro S; Osugi Y; Ikegame K; Kaida K; Fukunaga K; Higami T; Tada M; Tanaka K; Yanai M; Kimura T
    Int J Med Sci; 2020; 17(7):859-864. PubMed ID: 32308538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.